Aldeyra Therapeutics, Inc. (ALDX)


Stock Price Forecast

June 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aldeyra Therapeutics, Inc. chart...

About the Company

We do not have any company description for Aldeyra Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

19

Exchange

Nasdaq

$M

Total Revenue

19

Employees

$216M

Market Capitalization

-5.45

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ALDX News

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable

11h ago, source:

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...

Aldeyra: A Speculative Buy Amid Reproxalap's NDA Resubmission

10d ago, source:

Aldeyra Therapeutics offers a high-risk/high-reward investment opportunity with its Reproxalap program. Read why I consider ...

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease

7d ago, source: Eagle-Tribune

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

1mon ago, source: Nasdaq

Has Aldeyra Therapeutics, Inc. (ALDX) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer ...

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease

7d ago, source: Morningstar

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases ...

ALDX Aldeyra Therapeutics, Inc.

6d ago, source: Seeking Alpha

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Aldeyra Therapeutics Inc ALDX

20d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...